MacroGenics
Income Statement

Last updated:

Income statement is a financial statement that shows how profitable a business was over a given reporting period presenting its revenue, expenses or net income. MacroGenics's past years’ income statements indicate that its last revenue has decreased compared to the previous period by 61% to $58,749,000. The net income raised on -$9,058,000 and profit margin reached -15%. Total operating expenses were $217,215,000.

Profit Margin

MacroGenics, Inc. (NASDAQ:MGNX): Profit margin
2014 47.26M -38.31M -81.06%
2015 100.85M -20.14M -19.97%
2016 86.58M -58.52M -67.6%
2017 155.51M -19.62M -12.62%
2018 60.12M -171.45M -285.18%
2019 62.02M -151.81M -244.76%
2020 97.76M -117.78M -120.48%
2021 75.64M -190.85M -252.31%
2022 151.94M -120.02M -78.99%
2023 58.74M -9.05M -15.42%

MGNX Income Statement (2014 – 2023)

2023 2022 2021 2020 2019 2018 2017 2016 2015 2014
Revenue
Revenue
58.74M151.94M75.64M97.76M62.02M60.12M155.51M86.58M100.85M47.26M
Cost of revenue
8.22M7.38M2.65M193.20M195.30M00000
Gross profit
50.52M144.55M72.99M-95.43M-133.28M60.12M155.51M86.58M100.85M47.26M
Operating exp.
Research and development
166.58M207.02M214.57M193.20M195.30M190.82M147.23M122.09M98.27M70.18M
Selling and marketing
0000000000
Total operating expenses
217.21M265.97M275.78M228.82M239.20M231.32M177.65M146.62M121.03M85.57M
Operating income
-168.24M-121.41M-202.79M-131.06M-177.18M-171.20M-22.14M-60.04M-20.18M-38.31M
Other income (expenses), net
159.18M1.66M680K1.32M25.37M-247K2.51M1.51M42K2K
Income before tax
-9.05M-119.75M-202.11M-129.73M-151.81M-171.45M-19.62M-58.52M-20.14M-38.31M
Income tax expense
0263K-11.25M-11.95M0-247K-7.22M-7.60M0-1.82M
Net income
-9.05M-120.02M-190.85M-117.78M-151.81M-171.45M-19.62M-58.52M-20.14M-38.31M
Earnings per share
Basic EPS
-0.15-1.95-3.18-2.25-3.16-4.19-0.54-1.69-0.63-1.4
Diluted EPS
-0.15-1.95-3.18-2.25-3.16-4.19-0.54-1.69-0.63-1.4
Data sourceData sourceData sourceData sourceData sourceData sourceData sourceData sourceData sourceData source